Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01028430 · ClinicalTrials.gov registry record

B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging

A clinical trial, sponsored by Northwell Health.

Completed
Registry status
1,000
Enrollment target

NCT01028430: Completed study, sponsored by Northwell Health.

NCT01028430 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01028430 has completed, sponsored by Northwell Health.

COMPLETED
Registry status
1,000 participants
Enrollment target

Study Summary

B-CLL is the most prevalent leukemia in the Western hemisphere, accounting for \~25% of all leukemia's (1). This disease occurs virtually exclusively in the aging population, with the median age of diagnosis ranging between the mid 60s and the early 70s. Indeed, its occurrence before the age of 50 is quite unusual. This increase in occurrence with age is not unique to B-CLL; rather, it is characteristic several B cell lymphoproliferative disorders (e.g., non-Hodgkin's lymphoma, multiple myeloma). Gender and race also influence the development of B-CLL. Thus, the ratio of men: women is \~2:1 and the prevalence is increased in Caucasians. The rate of occurrence of B-CLL among Asians is significantly lower than for Caucasians and this does not increase with immigration to the West. DNA sequence analyses performed in our laboratory and in those of others indicate that B-CLL cells from unrelated patients share Ig V gene characteristics. These include the use of selected genes, the association of these genes with certain D and JH gene segments that code for unique CDR3 motifs, and the occasional occurrence of highly similar VHDJH + VLJL pairs. In \~50% cases, these rearranged genes are mutated, whereas in the others mutations are infrequent; this difference is related to the VH gene family used by the B-CLL cell.

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 1998-07
Est. Completion 2023-09
Northwell Health

370 total trials

What the finished NCT01028430 record still lists

NCT01028430 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT01028430 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01028430 about?

NCT01028430 is a clinical study titled "B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging". B-CLL is the most prevalent leukemia in the Western hemisphere, accounting for \~25% of all leukemia's (1). This disease occurs virtually exclusively in the aging population, with the median age of diagnosis ranging between the mid 60s and the early 70s. Indeed, its occurrence before the age of 50 i...

What is the current status of trial NCT01028430?

This trial is currently completed. The enrollment target is 1,000 participants. The study started on 1998-07. Estimated completion is 2023-09.

Who is sponsoring clinical trial NCT01028430?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01028430, the US trial registry maintained by the National Library of Medicine. NCT01028430 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.